🇺🇸 FDA
Patent

US 10543283

Intranasal administration of guanidinylated aminoglycosides

granted A61KA61K38/46A61K38/47

Quick answer

US patent 10543283 (Intranasal administration of guanidinylated aminoglycosides) held by The Regents of the University of California expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/46, A61K38/47, A61K39/39533, A61K47/549